Skip to ContentSkip to Navigation
About us Latest news News News articles

Neurodegenerative diseases and the protein quality control

10 October 2011

PhD ceremony: Mr. K. Seidel, 12.45 uur, Aula Academiegebouw, Broerstraat 5, Groningen

Dissertation: Neurodegenerative diseases and the protein quality control

Promotor(s): prof. H.H. Kampinga

Faculty: Medical Sciences

With increasing life-expectancy in the western world, diseases of old age are becoming more prevalent, in particular the neurodegenerative diseases. Here, certain components of the brain and spinal cord degenerate progressively. The symptoms are grave and have a severe impact on the patient’s lifespan and quality of life.

Some of these diseases occur sporadically without known cause (idiopathic), others are due to genetic risk factors or specific mutations. Many display a similar phenomenon: the aggregation of disease typical protein into microscopically visible lumps (aggregates), usually situated within neurons. The exact link from aggregating protein to neuronal cell death remains unresolved. Several systems are being studied for involvement in the disease processes. One of these is the Protein Quality Control (PQC), which clears old, and combats aggregated and aberrant proteins.

This thesis approaches the subject of neurodegenerative diseases from 2 angles. Part one is dedicated to the degenerative processes and protein aggregates. Here, the degeneration of the auditory system and a novel type of protein aggregation, as well as the high similarity of a genetic form of Parkinson’s disease to the idiopathic form is described. Part two concerns the response of the PQC in relation to protein aggregation. These data demonstrate that aggregation in neurodegenerative processes may ”escape” from the attention of the normal stress-regulated PQC system. They also demonstrate the existence of a stress response in astrocytes in degenerating areas, suggesting that upregulation of PQC systems in astrocytes may be important in combating neurodegeneration.

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.